Top of the Street: SOBI, Sonova, BAT, Imperial Brands

By Reuters News

- A round-up of notable broker activity this morning from Europe’s top-ranked* analysts:


** Jefferies upgrades Swiss hearing aid maker Sonova SOON.S to "hold" from "underperform", citing better market conditions and encouraging early feedback on new products. It raises its PT by 62% to CHF 275.

** Deutsche Bank cuts Swedish biopharmaceutical company SOBI SOBIV.ST to "hold" from "buy", citing Ionis' lowered Tryngolza sales forecast


INITIATIONS AND REINSTATEMENTS

** JPMorgan reinstates coverage of British tobacco group BAT BATS.L with "overweight" and a PT of 5,300p.

** It also reinstates coverage of peer Imperial Brands IMB.L with "neutral" and a PT of 3,200p.

(*Analyst rankings from Thomson Reuters StarMine. The scale is from 1-star to 5-star with 5 being the best. Analysts are ranked on earnings accuracy as well as relative performance of recommendations over trailing 12-month & 24-month periods.)

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.

The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.

To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.

Any information which could be construed as “investment research” has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.